$29M sweet spot round size
Most of their 8 investments are in rounds between $28M and $30M
2012
Splisense raised $29M on May 13, 2021
Investors: OrbiMed Advisors and Integra Holdings
Undisclosed raised undisclosed on January 1, 2018
Investors: Integra Holdings
Undisclosed raised undisclosed on January 1, 2018
Investors: Integra Holdings
Atox Bio raised $30M on December 4, 2017
Investors: Becker Group, Lundbeckfonden / Lundbeck Foundation, S.R. One Ltd, Adams Street Partners, Arix Bioscience plc, OrbiMed Advisors and Integra Holdings
Nectin Therapeutics raised undisclosed on January 1, 2017
Investors: Integra Holdings
Splisense raised undisclosed on January 1, 2016
Investors: Integra Holdings
Undisclosed raised undisclosed on January 1, 2014
Investors: Integra Holdings
Undisclosed raised undisclosed on January 1, 2014
Investors: Integra Holdings